A publication by scientists of the Anticancer Fund

Repurposing Infectious Diseases Vaccines Against Cancer

Liese Vandeborne, Pan Pantziarka, An M. T. Van Nuffel and Gauthier Bouche. Repurposing Infectious Diseases Vaccines Against Cancer. Frontiers in Oncology, 13 May 2021, doi: 10.3389/fonc.2021.688755.
A publication by scientists of the Anticancer Fund

Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research

Ciska Verbaanderd, Ilse Rooman, Isabelle Huys. Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research. Trials, (2021) 22:322, doi:10.1186/s13063-021-05273-x

Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable data

Gauthier Bouche, Eric Bouffet, Liese Vandeborne, Rica Capistrano, Nicolas André. Diffuse intrinsic pontine glioma: a clinic in Mexico, social media, and unpublishable data. The Lancet Oncology, Volume 22, Issue 5, P595-596, May 01, 2021, doi: 10.1016/S1470-2045(21)00009-7

How to optimize cancer research for the benefit of the patient?

A publication by scientists of the Anticancer Fund

A prospective phase II, randomised multi-center trial of a biomodulatory treatment with metronomic low-dose treosulfan, pioglitazone and clarithromycin versus nivolumab in patients with lung cancer, after platin failure (ModuLung).

Daniel Heudoble, Christian Schulz, Jürgen R. Fischer, Peter Staib, Thomas Wehler, Thomas Südhoff, Thomas Schichtl, Jochen Wilke, Joachim Hahn, Florian Lüke, Martin Vogelhuber, Sebastian Klobuch, Tobias Pukrop, Wolfgang Herr, Swantje Held, Kristine Beckers, Gauthier Bouche, Albrecht Reichle. A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung). Front. Pharmacol., 16 March 2021,doi.org/10.3389/fphar.2021.599598
A publication by scientists of the Anticancer Fund

An Open Access Database of Licensed Cancer Drugs

Pan Pantziarka, Rica Capistrano I, Arno De Potter, Liese Vandeborne and Gauthier Bouche. An Open Access Database of Licensed Cancer Drugs. Frontiers in Pharmacology, 2021, doi: 10.3389/fphar.2021.627574
A publication by scientists of the Anticancer Fund

The European Union and personalised cancer medicine

John A. Hickman, Ian F. Tannock, Lydie Meheus, Lisa Hutchinson. The European Union and personalised cancer medicine. European Journal of Cancer, 150 (2021) 95e98, doi.org/10.1016/j.ejca.2021.03.013

From lab to life: transforming childhood, adolescent and rare cancer care